Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,004 AUD | -20,00% |
|
-76,47% | -99,67% |
Vakgebied
Verkoop per activiteit
AUD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Asia Pacific
38,8
%
| 0 | 0,0 % | 7 | 38,8 % | - |
Canada
36,7
%
| 4 | 50,5 % | 7 | 36,7 % | +58,00% |
Europe
24,5
%
| 2 | 21,2 % | 5 | 24,5 % | +151,14% |
Verkoop per regio
AUD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Asia Pacific
38,8
%
| 0 | 0,0 % | 7 | 38,8 % | - |
Canada
36,7
%
| 4 | 50,5 % | 7 | 36,7 % | +58,00% |
Europe
24,5
%
| 2 | 21,2 % | 5 | 24,5 % | +151,14% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
William Lay
CEO | Chief Executive Officer | - | 17-09-21 |
John Griese
COO | Chief Operating Officer | 38 | 14-06-18 |
Gian Trepp
SAM | Sales & Marketing | - | - |
Winton Willesee
SEC | Corporate Secretary | 54 | 19-10-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bruce Linton
BRD | Director/Board Member | 57 | 17-01-22 |
Peter Hatfull
BRD | Director/Board Member | 71 | 30-11-22 |
Boaz Wachtel
FOU | Founder | - | 20-11-15 |
William Lay
CEO | Chief Executive Officer | - | 17-09-21 |
Micheline McKay
BRD | Director/Board Member | - | 17-01-22 |
Ben Quirin
BRD | Director/Board Member | - | 10-10-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 7 903 089 | 5 612 181 ( 71,01 %) | 0 | 71,01 % |
Bedrijfsgegevens
Melodiol Global Health Ltd.
145 Stirling Highway Suite 5 CPC
6009, Nedlends
+61 8 9389 3180
http://www.cresopharma.com![Adres Melodiol Global Health Limited(ME1)](https://cdn.zonebourse.com/static/address/30506561.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-99,67% | 121K | |
+55,08% | 815 mld. | |
+45,31% | 654 mld. | |
-6,70% | 354 mld. | |
+21,56% | 337 mld. | |
+9,94% | 302 mld. | |
+17,70% | 247 mld. | |
+2,04% | 229 mld. | |
+12,94% | 219 mld. | |
+9,58% | 171 mld. |